NDC 24840-1301 - ENT Kit
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24840-1301
- Package NDCs from labels
- 24840-1301-1, 24840-1301-2
- Manufacturer
- Centurion Medical Products | Hospira
- Effective date
- 2013-11-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ENT Kit - Centurion Medical Products | Hospira | Centurion Medical Products | Hospira | 2013-11-13 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24840-1301-1 | ENT Kit | 1 in 1 PACKAGE, COMBINATION | KIT | 1 | 1 | |
| 24840-1301-2 | ENT Kit | 10 in 1 CASE | KIT | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 24840-1301 | ENT KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | 2 package rows | 20140630_ff489b7c-ad25-4073-9a1c-5429ee6473bd.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | ENT KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | ENT KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ENT KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ENT KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ENT KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ENT KIT () KIT [CENTURION MEDICAL PRODUCTS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4bf5905-add7-1cb0-e053-2995a90a7334 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4c0df51-cc37-323d-e053-2995a90a154a | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 7a664a34-19fd-4a7b-ab4d-11299b32999e | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | fd6343a9-15a6-4894-b51f-122e4d6dbe79 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Seton Pharmaceuticals | 1c0abe84-5404-404e-b882-e910e4d43ffb | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 951862db-3a73-4d25-9d5b-e4111833f43b | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 6aa284d6-0212-4fb5-809d-c721aa6fe2ba | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | c4c16714-6b1f-857e-e053-2a95a90a74e4 | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a14ca7d9-de30-a303-e053-2a95a90a5304 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | c901016e-9293-79dd-e053-2a95a90a0fda | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8bc96bc-7876-4906-e053-2a95a90ae6ba | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e39435a3-1f69-78c5-e053-2995a90a7fc3 | 2024-01-27 | Warnings, Adverse reactions | ANDA080408 1737568 V13007Z41A |
| 0.5% LIDOCAINE HCl | 0.5% LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e52fe254-8872-35ce-e053-2a95a90a339e | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Target Up and Up Pain Relieving Cleansing | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | TARGET CORPORATION | 0f964747-be02-c715-e063-6294a90ad91e | 2024-01-25 | Warnings | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 95351883-ec37-f94a-e053-2995a90aa36a | 2024-01-25 | Warnings, Adverse reactions | V13007Z41A |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 451W47IQ8X |
| CIRCULATION HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, LACHESIS MUTUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA, | Energique, Inc. | 464d208b-3893-4ec6-9868-12ef6807b98d | 2024-01-23 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.